TMOD3 and glioblastoma: Since malignant tumors often exhibit marked heterogeneity, in order to investigate the expression of Tmod3 in different cell subtypes within the tumor, we measured the expression of Tmod3 by performing single-nuclear RNA-seq (snRNA-seq) with 6 cases of GBM and single-cell RNA-seq (scRNA-seq) with 8 cases of cervical cancer tissues.